Buten Matthew bought BHVN
January 2, 2024 · Form 4 insider transaction
Buten Matthew bought 96,250 shares of Biohaven Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
96,250
Price
$0.00
Total value
N/A
InsiderButen Matthew
RoleOfficer
CompanyBiohaven Ltd. (BHVN)
SecurityStock Options (Right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after96,250
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying this option vest in four equal installments on January 2, 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service with the Issuer at each vesting date.